Expected Revenue Growth:
[159 Pages Report] The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083
What This Report Will Provide?
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Major Growth Boosters:
The rising incidence of cancer, technological advancements, and advantages offered by IORT are the major factors driving the growth of the global intraoperative radiation therapy market.
COVID-19 Impact on the global Intraoperative radiation therapy market
The intraoperative radiation therapy market was significantly impacted by the COVID-19 pandemic. Various screening, diagnostic, and surgical procedures were restricted or postponed at hospitals and cancer treatment centers, which resulted in disruptions in the cancer diagnosis as well as treatment market. The pandemic also impacted the availability of healthcare resources.
Regional Growth Analysis:
The North American region is expected to account for the largest share of the intraoperative radiation therapy market. The growth in this market is mainly attributed to the increasing healthcare expenditure in the region, technological advancements, and high adoption of IORT products owing to the increasing incidence of cancer.
Key Market Players
The major players operating in the intraoperative radiation therapy market are ZEISS Group (Germany), iCAD, Inc. (US), Eckert Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems, Inc. (US), among others.
Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083
Recent Developments
- Elekta AB launched Geneva, a universal gynecological applicator for brachytherapy.
- Varian acquired Cancer Treatment Services International (CTSI), a US-based oncology solutions division that provides cancer care professional services to healthcare providers worldwide. The acquisition expanded Varian’s access to technology-driven cancer care .
- Varian launched the Bravos afterloader system for high-dose-rate (HDR) brachytherapy treatments
Frequently Asked Questions (FAQ):
- What is the expected addressable market value of major IORT products and services over a 5-year period?
- Which product segment is expected to garner highest traction within the Intraoperative radiation therapy market?
- What are the strategies adopted by the top market players to penetrate across emerging regions?
- What are the major factors expected to limit the growth of the Intraoperative radiation therapy market?
- What is the adoption pattern for novel IORT technology across major healthcare markets?
To speak to our analyst for a discussion on the above findings: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=245000083
